oHSV-scFv-anti-PD-1 virus (Brigham and Women's Hospital)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameoHSV-scFv-anti-PD-1 virus (Brigham and Women's Hospital)
Drug Alias NameNG34scFvPD-1PD-1 Checkpoint Inhibitor (Brigham and Women's Hospital)oncolytic HSV scFv anti-PD-1 virus (Brigham and Women's Hospital)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Oncolytic virus
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Brigham and Women's Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Brigham and Women's Hospital
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A